학술논문
P108 - Expert consensus recommendations for managing adverse events in patients with metastatic prostate cancer treated with poly(ADP-ribose) polymerase inhibitor (PARPi) + novel hormonal therapy (NHT) combination therapy
Document Type
Abstract
Author
Source
In European Urology Open Science November 2023 57 Supplement 1:S163-S163
Subject
Language
ISSN
2666-1683